VIKING THERAPEUTICS INC's ticker is VKTX and the CUSIP is 92686J106. A total of 185 filers reported holding VIKING THERAPEUTICS INC in Q3 2023. The put-call ratio across all filers is 0.42 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $566,784 | -30.5% | 51,200 | +1.8% | 0.00% | -50.0% |
| Q2 2023 | $815,363 | +149.8% | 50,300 | +156.5% | 0.00% | +100.0% |
| Q1 2023 | $326,457 | -53.8% | 19,607 | -77.7% | 0.00% | – |
| Q4 2019 | $706,000 | +24.1% | 88,000 | +6.5% | 0.00% | – |
| Q3 2019 | $569,000 | -26.7% | 82,667 | -11.6% | 0.00% | – |
| Q2 2019 | $776,000 | -60.7% | 93,476 | -53.0% | 0.00% | -100.0% |
| Q1 2019 | $1,977,000 | +262.8% | 198,844 | +179.2% | 0.00% | – |
| Q4 2018 | $545,000 | +141.2% | 71,212 | +447.8% | 0.00% | – |
| Q3 2018 | $226,000 | +804.0% | 12,999 | +401.3% | 0.00% | – |
| Q2 2018 | $25,000 | -24.2% | 2,593 | -65.3% | 0.00% | – |
| Q1 2018 | $33,000 | +10.0% | 7,474 | 0.0% | 0.00% | – |
| Q4 2017 | $30,000 | – | 7,474 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| APIS CAPITAL ADVISORS, LLC | 148,000 | $1,638,360 | 2.12% |
| Sio Capital Management, LLC | 595,002 | $6,586,672 | 2.04% |
| 5AM Venture Management, LLC | 585,000 | $6,475,950 | 1.86% |
| Artia Global Partners LP | 383,580 | $4,246,231 | 1.76% |
| Integral Health Asset Management, LLC | 800,000 | $8,856,000 | 1.23% |
| Boxer Capital, LLC | 2,000,000 | $22,140,000 | 1.18% |
| DAFNA Capital Management LLC | 319,655 | $3,538,581 | 1.10% |
| Affinity Asset Advisors, LLC | 332,600 | $3,681,882 | 1.04% |
| MPM BioImpact LLC | 325,000 | $3,597,750 | 0.96% |
| Affinity Asset Advisors, LLC | 300,000 | $3,321,000 | 0.93% |